Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2010
09/01/2010EP2223696A1 Mesenchymal CD34- stem cells for use in wound healing gene therapy
09/01/2010EP2223110A1 Markers of matrix gene expression and cellular differentiation in chondrocytes
09/01/2010EP2222839A2 Methods and compositions for modulating differentiation of pluripotential cells
09/01/2010EP2222837A2 Methods for the induction of a cell to enter the islet 1+ lineage and a method for the expansion thereof
09/01/2010EP2222836A1 Method for producing dendritic cells
09/01/2010EP2222709A2 Antigen-binding constructs
09/01/2010EP2222331A2 An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
09/01/2010EP2007882B1 Method for preparing differentiated avian cells and genes involved in maintaining pluripotency
09/01/2010EP1867716B1 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same
09/01/2010EP1613347B1 Humanized antibodies that recognize beta amyloid peptide
09/01/2010EP1572969B1 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
09/01/2010EP1439897B1 Methods for separating rare cells from fluid samples
09/01/2010EP1427815B1 Methods for the industrial production of vaccines
09/01/2010EP1339866B1 Human testis specific serine/threonine kinase
09/01/2010EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
09/01/2010EP1305437B1 Expression of biologically active polypeptides in duckweed
09/01/2010CN1703509B Reversible, parallel and multitask cloning method and kit
09/01/2010CN101821403A Cell for use in the production of exogenous protein, and production process using the cell
09/01/2010CN101821375A Barley with low levels of hordein
09/01/2010CN101821283A Use of SLIT, NEPHRIN, ephrin or semaphorin for treatment of cartilage diseases
09/01/2010CN101820929A Method for preparing porous scaffold for tissue engineering
09/01/2010CN101820890A Population of adult stem cells derived from cardiac adipose tissue and use thereof in cardiac regeneration
09/01/2010CN101818170A Plant expression vector for vascular peculiar promoter to control antimicrobial protein gene and method for cultivating greensickness-resistant cotton
09/01/2010CN101818168A Application of AtNRT1.8 gene to strengthening resistance of crops to stress of heavy metals or salts
09/01/2010CN101818157A Artificially designed Bt insect-resistant gene and application thereof
09/01/2010CN101818149A Universal strong promoter among species derived from white spot syndrome virus and application thereof
09/01/2010CN101818145A Control of gene expression
09/01/2010CN101818129A Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby
09/01/2010CN101818128A Superparamagnetic iron oxide labeled human pancreas cancer cell strain as well as labeling method and application thereof
09/01/2010CN101818127A Method for separating and culturing mouse primitive spermatogonia
09/01/2010CN101818126A Stem cell separating and purifying method
09/01/2010CN101817879A Metallothionein and encoding gene and application thereof
09/01/2010CN101817877A Active fragment of anti-opioid peptide
09/01/2010CN101817875A Rice adventitious root protruding control gene OsDARE1 and application thereof
09/01/2010CN101817874A New anti-drought and cold-resistant gene CaDHN1 in caragana korshinskii
09/01/2010CN101816779A Human nuclear clusterin, vector and application thereof
09/01/2010CN101280006B Protein related to tolerance to Fe deficiency of plant, coding genes and application thereof
08/2010
08/31/2010US7786357 Soybean cultivar 6819331
08/31/2010US7786356 Method for the production of calendic acid, a fatty acid containing delta 8,10,12 conjugated double bonds and related fatty acids having a modification at the delta 9 position
08/31/2010US7786355 Transgenic microorganism for use in the generation of polyhydroxyalkanoates such as 3-hydroxyoctanoic acid
08/31/2010US7786284 Polynucleotides encoding IL-17 receptor A antigen binding proteins
08/31/2010US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents
08/31/2010US7786275 Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cells
08/31/2010US7786272 bind to biomarker overexpressed in colon or lung tumor cells
08/31/2010US7786271 Antibodies that inhibit TSLP activity
08/31/2010US7786269 The antibodies or fragments specifically bind to an extracellular epitope of an Epstein Barr Virus latent membrane protein; anticarcinogenic agents; cancer vaccines
08/31/2010US7786264 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
08/31/2010US7786263 Human T1R2 taste receptor polypeptides
08/31/2010US7786261 protein of an ectodomain of a transforming growth factor beta membrane-bound receptor and a peptide subunit of an alpha -helical coiled-coil; selecting compounds capable of inhibiting ligand binding and kinase activity
08/31/2010US7786089 modulate an immune response through toll like receptors; 5'-TCGiTCGiTTCTC-Y-GiCTTGiCAAGiCT-5' (SEQ ID NO: 1), wherein X is a glycerol linker, Y is C3-1inker and Gl is 7-deazaguanosine
08/31/2010US7785898 obtaining a sample of maternal blood that contains fetal cells, detecting and distinguishing a maternal antibody from the mother bound to a paternally inherited fetal antigen on the fetal cell which formed a fetal cell-maternal antibody complex, to thereby identify the fetal cell
08/31/2010US7785888 Adeno-associated viral vector for use as heterologous gene transfer agent
08/31/2010US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease
08/31/2010US7785885 Rescue of plant cell cultures and suspensions after cryopreservation-induced damage
08/31/2010US7785884 Propagating conifer cotyledonary somatic embryos on porous marterials/bioscaffolds
08/31/2010US7785883 integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals; used to test the efficacy of vaccine candidates in vitro and thus is useful to accelerate vaccine development
08/31/2010US7785882 Separation of mixture; insertion a nucleic acid which codes fluorescent protein; gene expression; neuron progenitor cell
08/31/2010US7785880 Permitting the increased production of recombinant proteins; culturing; introducing into the cells agents that inhibit senescence or that promote cell survival
08/31/2010US7785879 Pregnane X receptor compositions, crystals and uses thereof
08/31/2010US7785877 Bovine immunodeficiency virus (BIV) based vectors
08/31/2010US7785876 culturing the cells in a medium conditioned by prostate epithelial cells; shows that keratinocytes can be replaced by another cell type that produces the same or similar signaling molecule in order to obtain the response in a mesenchymal cell
08/31/2010US7785859 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
08/31/2010US7785855 Nucleic acids encoding polypeptides having amylase activity and methods of making and using them
08/31/2010US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
08/31/2010US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring
08/31/2010US7785833 Methods and means for producing proteins with predetermined post-translational modifications
08/31/2010US7785831 Overexpressing an endogenous gene in a cell, comprising introducing a vector containing a transcriptional regulatory sequence into the cell, allowing the vector to integrate into the genome of the cell by non-homologous recombination
08/31/2010US7785822 Assays for the detection of biliverdin in birds and reptiles
08/31/2010US7785811 Using lutetium label probes to detect tumor secreted antigens and diagnose/prognose cell proliferative disorders
08/31/2010US7785810 Detection of adhesion of cancer cells to a matrix coated with adhesion molecules; inhibiting the metastatic activity by administration of a dipeptidyl peptidase IV inhibitor.
08/31/2010US7785809 Nucleic acids and proteins of insect Or83b odorant receptor genes and uses thereof
08/31/2010US7785806 in vitro comprising preparing a cell culture comprising dendritic cells primed with an antigen, then adding syngeneic and allogeneic lymphocytes to the cell culture and measuring the lymphocyte response to the antigen and comparing the response control culture in which the antigen was not used
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785803 Antibody diagnostic kits and methods of use
08/31/2010US7785802 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste
08/31/2010US7785791 Polypeptide variants with altered effector function
08/31/2010US7785602 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
08/31/2010US7785599 Albumin fusion proteins
08/31/2010US7785596 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders
08/31/2010US7785590 Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1)
08/31/2010US7785586 Capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two or more, mutated forms of the HBsAg antigen
08/31/2010US7785583 administering imiquimod and carrier to a site to induce local inflammation at the site, then administering antigen-loaded antigen presenting cells, to eliciting an immune response; immunology
08/31/2010CA2281262C Anti-human medullasin monoclonal antibody, process for producing the same and immunoassay using the same
08/31/2010CA2190371C Receptor for oncostatin m
08/26/2010WO2010096746A1 Methods and compositions for the differentiation of stem cells
08/26/2010WO2010096693A2 Methods and materials for generating t cells
08/26/2010WO2010096594A2 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
08/26/2010WO2010096588A2 Cell culture media containing combinations of proteins
08/26/2010WO2010096496A2 Methods of neural conversion of human embryonic stem cells
08/26/2010WO2010096418A2 Antibody molecules having specificity for human ox40
08/26/2010WO2010096177A1 Isolated monocyte populations and related therapeutic applications
08/26/2010WO2010096170A2 Inhibition of trna synthetases and therapeutic applications thereof
08/26/2010WO2010096044A1 In vivo quantitative screening test for anti-metastasis treatment efficacy
08/26/2010WO2010095917A1 Monoclonal antibodies against vaginolysin
08/26/2010WO2010095721A1 Fused monooxygenase and process for producing oxide using same
08/26/2010WO2010095685A1 Culture medium and method to induce differentiation into bone cells
08/26/2010WO2010095684A1 Culture medium and method for inducing differentiation into adipocytes
08/26/2010WO2010095461A1 Novel monoclonal antibody, and use thereof
08/26/2010WO2010095428A1 Foxm1 peptides and vaccines containing the same
08/26/2010WO2010095043A1 Compositions for treating an allergic or asthmatic condition